Causes of ABO forward and reverse grouping discrepancy: 75 cases
10.13303/j.cjbt.issn.1004-549x.2022.07.018
- VernacularTitle:75例ABO血型正反定型不符原因调查与分析
- Author:
Wengang ZHU
1
;
Lingbo LI
2
;
Jing ZHONG
3
Author Information
1. Fuyang People′s Hospital, Fuyang People′s Hospital Affiliated to Anhui Medical University, Fuyang 236006, China
2. R&D Department of Changchun Boxun Biotechnology Co., Ltd
3. Shaoyang Central Hospital
- Publication Type:Journal Article
- Keywords:
ABO blood groups;
forward and reverse grouping discrepancy;
molecular biology;
subtypes
- From:
Chinese Journal of Blood Transfusion
2022;35(7):751-754
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To analyze the causes and solutions of ABO forward and reverse grouping discrepancy, and to ensure the safety of blood transfusion in clinical. 【Methods】 Samples from 75 patients with discrepancy between forward and reverse grouping in December 2019 and March 2022 were tested and analyzed in combination with saline method(forward and reverse grouping), direct antiglobulin test, antibody screening, antibody identification, increasing plasma volume, incubation enhancement test at 4℃, absorption-eluation test and molecular biological tests. 【Results】 Causes for abnormal reverse typing were as follows : weak antibody in 11 cases(14.67%), unexpected antibody in 19 cases(25.33%), inverted albumin and globulin ratios in 9 cases(12.00%), increased white blood cells in 3 cases(4.00%), inadequate anticoagulation in 3 cases(4.00%), bone marrow transplantation in 2 cases(2.67%), multiple myeloma in 4 cases(5.33%), acute gastrointestinal bleeding in 3 cases(4.00%). Causes for abnormal forward typing were as follows: self-coagulating in 1 case(1.33%), acute leukemia in 7cases(9.34%), post-transplantation in 1 case(1.33%). Causes for abnormal forward/reverse typing: acute leukemia in 1 case(1.33%), condensin syndrome in 1 case(1.33%), autoimmune hemolytic anemia in 6 cases(8.00%), subtype in 4 cases(5.33%). Results of genotying in 7 cases were as follows: B(A) 04 for 1 case, B(A)02 2 cases, AB3 1case, A1 2 cases, and 1case with new genotype. 【Conclusion】 For patients with forward and reverse typing discrepancy for ABO blood group, several studying methods, such as clinical/serological tests inquiring, absorption-eluation tests and molecular biological tests, should be combined to ensure blood transfusion safety.
